Abstract: A display device includes a substrate, a semiconductor layer disposed on the substrate, and including a first channel portion, a second channel portion, a connecting portion disposed between the first channel portion and the second channel portion, and electrode regions, a first insulating layer disposed on the semiconductor layer, a gate conductor disposed on the first insulating layer and including a first gate electrode overlapping the first channel portion and a second gate electrode overlapping the second channel portion, signal lines disposed on the substrate, a first electrode electrically connected to at least one of electrode regions of the semiconductor layer, an emission layer disposed on the first electrode, and a second electrode disposed on the emission layer, and the first channel portion and the second channel portion of the semiconductor layer each have a first width greater than a second width of the connecting portion.

Abstract: A display device including a pixel electrode, and a pixel circuit electrically connected to the pixel electrode. The pixel circuit includes a first transistor including sub-transistors electrically connected to each other through a first common node, a second transistor including sub-transistors electrically connected to each other through a second common node, a first electrode electrically connecting the first common node with the second common node, and a second electrode disposed to overlap the first electrode and electrically connected to a direct current power source.

Abstract: The present invention relates to an injection for protecting ischemic myocardium, and preparation method for the injection. The emulsion for injection comprises, in parts by weight: 1-5 parts of N-suberoylanilide hydroxamic acid, 0.2-12.5 parts of n emulsifying agent, 2-100 parts of oil for injection, 0.02-5 parts of a solubilizer, 0.03-0.4 part of oleic acid, 0.4-12.5 parts of glycerinum, and the balance being water for injection. The emulsion for injection can effectively be used for increasing local drug concentration of the N-suberoylanilide hydroxamic acid in lipophilic organs such as angiocarpy and/or tissues before a cardiac interventional operation, increasing the bioavailability of the N-suberoylanilide hydroxamic acid, reducing general side effects of the N-suberoylanilide hydroxamic acid, realizing effective protection on myocardium under an ischemic or reperfusion injury state, and reducing or avoiding the occurrence of myocardial infarction.

Abstract: A secure electronic file transfer system and methods of its use are provided. The sender issues a request to the DAD (Digital Asset Distribution) system causing files residing on local or remote computers to be transferred to the recipient via application and TCP/IP protocols. Client software may be automatically downloaded and installed to the sending and/or receiving device to facilitate the packaging and transfer of said file to a DAD server, and said file may optionally be propagated from said DAD server to additional DAD servers and other non-DAD servers.